Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Pancreatic Neoplasms 71Breast Neoplasms 45Neoplasms 29Carcinoma, Non-Small-Cell Lung 29Triple Negative Breast Neoplasms 21Neoplasm Metastasis 14Adenocarcinoma 13Squamous Cell Carcinoma of Head and Neck 8Lung Neoplasms 8Colorectal Neoplasms 8Melanoma 7Carcinoma 7Head and Neck Neoplasms 6Digestive System Neoplasms 6Cholangiocarcinoma 6Small Cell Lung Carcinoma 5Pancreatic Diseases 5Pancreatic Adenocarcinoma 5Ovarian Neoplasms 5Digestive System Diseases 5Carcinoma, Pancreatic Ductal 5Stomach Neoplasms 4Sarcoma 4Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasms by Site 4Gallbladder Neoplasms 4Fallopian Tube Neoplasms 4Endocrine Gland Neoplasms 4Carcinoma, Squamous Cell 4

Interventions

Taxes 1Immunoglobulin G 1Disulfides 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Cervical Adenocarcinoma × 130-nm albumin-bound paclitaxel × Clear all
NCT02020707 2024-07-26

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Mayo Clinic

Phase 1 Completed
43 enrolled
DermatologicGenitourinaryGynecologicOther solid neoplasmSarcoma

Cervical Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡